Literature DB >> 7022799

Serological characterization of antibodies eluted from chronically rejected human renal allografts.

T Mohanakumar, J C Waldrep, M Phibbs, G Mendez-Picon, A M Kaplan, H M Lee.   

Abstract

Serum samples collected pre- and post-transplant nephrectomy were screened for alloreactive lymphocytotoxins. Three patients demonstrated circulating anti-B cell antibodies with markedly increased cytotoxicity titers after nephrectomy, suggesting that there was active binding of antibodies within the renal allograft. Two of the postnephrectomy serum samples after absorption with platelets and B cells reacted by immunofluorescence with cultured primary kidney cells but not against B or T cells from the same donor. To clarify further the role of such alloreactive antibodies, eluates were prepared from 14 rejected renal allografts and were analyzed for reactivity to cultured primary kidney cells against different leukocyte targets and endothelial cells. Reactivity toward B cells and kidney cells was demonstrated with 80% of the eluates. Absorption experiments of the positive eluates demonstrated multiple types of alloreactive antibodies. In addition to anti-DR activity, eluates had antibodies reactive to kidney cell antigens, monocytes, macrophages, endothelial cells, and polymorphonuclear leukocytes. The demonstration of multispecific alloantibodies in eluates of rejected kidneys is consistent with an important role(s) in maintenance and/or rejection of the kidney allograft.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022799     DOI: 10.1097/00007890-198107000-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine.

Authors:  Maria Lucia L Madariaga; Sebastian G Michel; Glenn M La Muraglia; Smita Sihag; David A Leonard; Evan A Farkash; Robert B Colvin; Curtis L Cetrulo; Christene A Huang; David H Sachs; Joren C Madsen; James S Allan
Journal:  Transplantation       Date:  2015-07       Impact factor: 4.939

2.  Development of immunological assays to monitor pulmonary allograft rejection.

Authors:  A C Cunningham; J A Kirby; I W Colquhoun; P A Flecknell; T Ashcroft; J H Dark
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

Review 3.  Is There a Role for Natural Antibodies in Rejection Following Transplantation?

Authors:  Emmanuel Zorn; Sarah B See
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

Review 4.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  The paradoxical functions of B cells and antibodies in transplantation.

Authors:  Marilia I Cascalho; Brian J Chen; Mandy Kain; Jeffrey L Platt
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

6.  Immune responses to self-antigens (autoimmunity) in allograft rejection.

Authors:  Sabarinathan Ramachandran; Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Clin Transpl       Date:  2012

7.  Cryptic B cell response to renal transplantation.

Authors:  R J Lynch; I A Silva; B J Chen; J D Punch; M Cascalho; J L Platt
Journal:  Am J Transplant       Date:  2013-06-10       Impact factor: 8.086

Review 8.  Clinical relevance of HLA antibody monitoring after kidney transplantation.

Authors:  Christian Morath; Gerhard Opelz; Martin Zeier; Caner Süsal
Journal:  J Immunol Res       Date:  2014-10-13       Impact factor: 4.818

Review 9.  The Role of Major Histocompatibility Complex in Organ Transplantation- Donor Specific Anti-Major Histocompatibility Complex Antibodies Analysis Goes to the Next Stage.

Authors:  Tsukasa Nakamura; Takayuki Shirouzu; Katsuya Nakata; Norio Yoshimura; Hidetaka Ushigome
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.